Delage, Maļa <br/><br/>
Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.  [electronic resource] 

 -  Acta dermato-venereologica  Mar 2011 
 - 169-71 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1651-2057 
<br/><br/><label>Standard No.: </label>10.2340/00015555-1025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>C-Reactive Protein--metabolism<br/>Drug Eruptions<br/>Female<br/>Hidradenitis Suppurativa--blood<br/>Humans<br/>Infliximab<br/>Leukocyte Count<br/>Male<br/>Middle Aged<br/>Neutrophils--metabolism<br/>Pain<br/>Quality of Life<br/>Retrospective Studies<br/>Treatment Outcome<br/>Young Adult